
Sign up to save your podcasts
Or
If you take a biologic drug to manage your arthritis, you might be facing some unexpected decisions as more competitors to brand-name biologics — called biosimilars — become available in the U.S. This year, at least eight biosimilars to the self-injectible biologic Humira are coming to market. Learn more about these drugs and what questions to ask your doctor and insurance company.
*Visit the Live Yes! With Arthritis Podcast episode page get show notes, additional resources and read the full transcript: https://www.arthritis.org/liveyes/podcast/new-podcast/ep-75-biosimilars-what-to-expect *
We want to hear from you. Tell us what you think about the Live Yes! With Arthritis Podcast. Get started by emailing [email protected].
Special Guest: Anna Hyde.
4.6
5858 ratings
If you take a biologic drug to manage your arthritis, you might be facing some unexpected decisions as more competitors to brand-name biologics — called biosimilars — become available in the U.S. This year, at least eight biosimilars to the self-injectible biologic Humira are coming to market. Learn more about these drugs and what questions to ask your doctor and insurance company.
*Visit the Live Yes! With Arthritis Podcast episode page get show notes, additional resources and read the full transcript: https://www.arthritis.org/liveyes/podcast/new-podcast/ep-75-biosimilars-what-to-expect *
We want to hear from you. Tell us what you think about the Live Yes! With Arthritis Podcast. Get started by emailing [email protected].
Special Guest: Anna Hyde.
1,700 Listeners
822 Listeners
12,533 Listeners
3,451 Listeners
7,508 Listeners
32,001 Listeners
3,360 Listeners
2,616 Listeners
9,317 Listeners
2,539 Listeners
2,006 Listeners
8,226 Listeners
20,787 Listeners
1,226 Listeners
308 Listeners